Meningitis B – Important Patient Update
We understand there is ongoing concern following recent reports of a Meningitis B outbreak in Kent.
We would like to reassure patients and share the latest key information:
- The current cases are linked to a specific cluster and close-contact settings. The overall risk to the general public remains low.
- Meningitis B spreads through close, prolonged contact such as coughing, kissing, or sharing drinks – not casual contact.
- Anyone born before September 2015 is unlikely to have received the Men B vaccine, as it was only introduced into routine NHS schedule from that time.
- The NHS vaccination programme currently focuses on infants and specific high-risk groups. There is no wider rollout at present.
- Men B (Meningococcal B) vaccine is routinely offered to babies at 8 weeks, 12 weeks and 1 year. Babies who missed these doses can catch up to 2 years of age.
- Then Men B vaccine is not routinely offered to children over 2 years or adults unless they are in an at-risk group.
- Some people at higher risk may be offered the vaccine, including those with: Problems with their spleen (asplenia or splenic dysfunction) or with certain immune system conditions (complement disorders)
- MenACWY vaccine. This vaccine protects against four types of meningococcal bacteria (A, C W and Y). Offered routinely in school Year 9 (age 13-14). Available up to age 25 if missed.
- What if vaccinations are incomplete? If you or your child have missed any routine vaccinations, we can help arrange catch-up doses in line with national guidance. We are in the process of inviting any children that are overdue or adults that are at higher risk in for catch-up vaccines.
- UKHSA are managing the situation closely, including offering antibiotics and vaccines to those identified as close contacts of confirmed cases.
- The Men B vaccine is available privately; however, there is currently no new national guidance recommending vaccination outside of existing NHS eligibility.
We will continue to monitor official guidance and provide updates if anything changes.
For more information:
